why would ncm go after sgx when goldfields has a 19.9% stake secured...that would be a poison pill for any potential acquirer...am sure goldfields would not be a willing seller.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025